Harvard Bioscience Inc
NASDAQ:HBIO
Harvard Bioscience Inc
Revenue
Harvard Bioscience Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Harvard Bioscience Inc
NASDAQ:HBIO
|
Revenue
$112.3m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
1%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.9B
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Revenue
$2.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
8%
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
Harvard Bioscience Inc
Revenue Breakdown
Breakdown by Geography
Harvard Bioscience Inc
Total Revenue:
112.3m
USD
|
United States:
48.2m
USD
|
Europe:
32.8m
USD
|
Greater China:
18.5m
USD
|
Rest Of The World:
12.8m
USD
|
Breakdown by Segments
Harvard Bioscience Inc
Total Revenue:
112.3m
USD
|
Instruments, Equipment, Software, And Accesso...:
105.7m
USD
|
Service, Maintenance, And Warranty Contracts:
6.5m
USD
|
See Also
What is Harvard Bioscience Inc's Revenue?
Revenue
112.3m
USD
Based on the financial report for Dec 31, 2023, Harvard Bioscience Inc's Revenue amounts to 112.3m USD.
What is Harvard Bioscience Inc's Revenue growth rate?
Revenue CAGR 10Y
1%
Over the last year, the Revenue growth was -1%. The average annual Revenue growth rates for Harvard Bioscience Inc have been 3% over the past three years , -1% over the past five years , and 1% over the past ten years .